At 83, Khorakiwala created life-saving medicine against all odds.

New Delhi. When most people relax at the age of 80, then Walkhart Chairman Habib Khorakiwala is making a new beginning. Even at the age of 83, his enthusiasm is the same, just like a young startup founder is about his first idea. Khorakiwala, who is engaged in the mission to give a new direction to Walkhart, is now focusing on such drugs, which can protect the world from the most important and most difficult diseases. Especially, antibiotics, bacterial drugs, which are now slowly ending.Jainich: When no medicine works, it should work
The drug named Jainich made by Khorakiwala is affecting the infections that had no cure till now. This drug saved the life of a cancer patient in America when all the options were over. In India too, this drug is giving 20 per cent better results, especially in cases of UTI (urinary infection). Khorakiwala says that ‘If someone does not understand the price of our medicine in the deal, we will move forward alone’.

The story of the return of WalkhartIn 2009, the company failed to repay foreign debt. FDA found flaws in factories. Stock fell, investors lost confidence. But Khorakiwala did not give up. They sold hospitals, nutrition business and manufacturing units, but did not handle the research wing. He believed that if you want to do research, do it with full vigor, otherwise do not do it.

Research wins when the whole world gives defeat
Medicines like WCK 5222 i.e. Jainich, and MIQNAF have become expected not only for India but doctors around the world. According to Khorakiwala, these drugs work on diseases on which old medicines have been neutralized. His dream is that these medicines should be found in India at a low price. Even if they are treated up to 10-15 thousand dollars in America.

Those who have seen small investors, they have stokes, they increased their share in this stock, do you have?Focus on research, manufacturing outsourced
Khorakiwala clearly said that now he will not do the work of making medicine for America himself. Will outsource everything so that the focus is only on research. His team is now working on the next medicine, which can be taken orally and will be as effective as Jainich. The treatment that the world is most needed can come from India. Every year 1 million people in India die from multi-drug resistance, which is four times more than the deaths of Kovid. In such a situation, medicines like Jainich are not only a commercial success, but also a moral responsibility.